Klinisch orientierter Schwerpunkt
FB 04 - Universitätsmedizin / Johannes Gutenberg-Universität Mainz
El-Khoueiry, Anthony B.; Kim, Richard D.; Harris, William Proctor et al.
Updated results of a phase 1b study of regorafenib (REG) 80 mg/day or 120 mg/day plus pembrolizumab (PEMBRO) for first-line treatment of advanced hepatocellular carcinoma (HCC).JOURNAL OF CLINICAL ONCOLOGY. Bd. 39. H. 15. 2021
Singer, Susanne; Kojima, Erika; Deppisch, Larissa et al.
What is the best time for psychosocial counselling from the perspective of cancer patients and their relatives? A multi-centre qualitative studyCOUNSELLING & PSYCHOTHERAPY RESEARCH. Bd. 22. H. 3. 2021 S. 558-568
Schmidt, Marcus; Hoenig, Arnd; Denkert, Carsten et al.
What is tumor agnostic therapy?GYNAKOLOGE. Bd. 54. H. 5. 2021 S. 334-340
Ratzel, Eileen; Gerlach, Christina; Pretzell, Ina et al.
"But you need a Questionnaire Like This": Real Life Experience of Quality of Life Assessment in Outpatients with Lung and Prostate Cancers - A Longitudinal Cohort StudyONCOLOGY RESEARCH AND TREATMENT. Bd. 43. 2020 S. 141-142
Maasberg, Sebastian; Bacher, Maria; Rinke, Anja et al.
"Routine Usage of Molecular Targeted Therapies (Everolimus and Sunitinib) and Temozolomide Based Chemotherapy in Neuroendocrine Neoplasia and Its Outcome"ONCOLOGY RESEARCH AND TREATMENT. Bd. 43. 2020 S. 43-44
Heimes, A. S.; Fries, P.; Stergiou, N. et al.
(TA)MUC1 as a potential new target for breast cancer therapyGEBURTSHILFE UND FRAUENHEILKUNDE. Bd. 80. H. 10. 2020 S. E213-E213
Kropp, Korbinian N.; Schaeufele, Tim J.; Fatho, Martina et al.
A bicistronic vector backbone for rapid seamless cloning and chimerization of alpha beta T-cell receptor sequencesPLOS ONE. Bd. 15. H. 9. 2020
Kaina, Bernd
A genome-wide screening for DNA repair genes: much more players than hitherto knownSIGNAL TRANSDUCTION AND TARGETED THERAPY. Bd. 5. H. 1. 2020
Weissinger, Eva M.; Metzger, Jochen; Schleuning, Michael et al.
A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapyLEUKEMIA. 2020
Lopez, Juanita S.; Camidge, Ross; Iafolla, Marco et al.
A phase Ib study to evaluate RO7198457, an individualized Neoantigen Specific immunoTherapy (iNeST), in combination with atezolizumab in patients with locally advanced or metastatic solid tumorsCANCER RESEARCH. Bd. 80. H. 16. 2020